We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$86.5M
AUM Growth
-$66.5M
Cap. Flow
-$70.6M
Cap. Flow %
-81.66%
Top 10 Hldgs %
8.13%
Holding
435
New
164
Increased
25
Reduced
63
Closed
183

Top Buys

Rank Stock Value
1
MLKN icon
MillerKnoll
MLKN
+$754K
2
LEN icon
Lennar Class A
LEN
+$740K
3
HXL icon
Hexcel
HXL
+$733K
4
CNK icon
Cinemark Holdings
CNK
+$732K
5
FAF icon
First American
FAF
+$732K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.61%
2 Industrials 15.51%
3 Financials 14.29%
4 Technology 14.02%
5 Healthcare 12.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
426
DELISTED
Alexion Pharmaceuticals
ALXN
-12,798
Closed -$1.29M
GRUB
427
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
-1,108
Closed -$131K
IPHI
428
DELISTED
INPHI CORPORATION
IPHI
$0 ﹤0.01%
1
-7,305
-100% -$502K
TIF
429
DELISTED
Tiffany & Co.
TIF
-15,102
Closed -$1.28M
TCO
430
DELISTED
Taubman Centers Inc.
TCO
-32,812
Closed -$1.28M
PTLA
431
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-23,633
Closed -$687K
MDCO
432
DELISTED
Medicines Co
MDCO
-23,536
Closed -$988K
VIAB
433
DELISTED
Viacom Inc. Class B
VIAB
-25,646
Closed -$641K
TSS
434
DELISTED
Total System Services, Inc.
TSS
-503
Closed -$68K
STL
435
DELISTED
Sterling Bancorp
STL
-33,561
Closed -$640K

Similar funds

Neo Ivy Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Neo Ivy Capital Management held 435 positions worth $86.5M, down 43% from $153M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Neo Ivy Capital Management withdrew a net $70.6M in Q4 2019, closing 183 positions and reducing 63 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.29M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

Against the trend, Neo Ivy Capital Management opened a new position in MillerKnoll worth $678K.

  • Neo Ivy Capital Management's largest Q4 2019 buy was MillerKnoll: 16,277 shares worth $678K.
  • Neo Ivy Capital Management added most to CVS Health in Q4 2019, an estimated $657K increase.
  • Neo Ivy Capital Management's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $1.34M.
  • Neo Ivy Capital Management fully exited Alexion Pharmaceuticals in Q4 2019, selling an estimated $1.29M.
  • Neo Ivy Capital Management's ten largest holdings make up 8.1% of its $86.5M portfolio in Q4 2019.
  • Neo Ivy Capital Management opened 164 new positions and closed 183 in Q4 2019.
  • Neo Ivy Capital Management's portfolio value fell 43% quarter-over-quarter to $86.5M.

Based on Neo Ivy Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.